|LamdaGen Plasmonic ELISA|
Need central-lab-grade quantitation for high-speed immunoassays? LamdaGen developed a nano-based technology for mobile and POC diagnostics. The company’s single-step, high-sensitivity immunoassay is precisely quantitative in the low femtomolar concentration range. Ideal for in vitro and POC diagnostics, these very rapid diagnostic assays show clinical promise in cardiovascular health, infectious disease, cancer, drug abuse, veterinary care, and contaminant monitoring. The Menlo Park, CA-based company’s plasmonic ELISA boasts 20-minute assay times and multiplexed panels. It licenses its technology to companies to integrate into mobile POCs.
|[image courtesy of LAMDAGEN CORP.]|
Correction: An earlier version of this post incorrectly referred to the device as the LambdaGen Plasmodic ELISA. In fact, it is the LamdaGen Plasmonic ELISA.